Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma: an analysis of melanoma outcomes in CTEP-sponsored phase I trials 1995-2011. [electronic resource]
Producer: 20140122Description: 152-8 p. digitalISSN:- 1473-5636
- Antineoplastic Agents, Alkylating -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase III as Topic
- Dacarbazine -- adverse effects
- Female
- Humans
- Immunotherapy
- Male
- Melanoma -- drug therapy
- Middle Aged
- Retrospective Studies
- Skin Neoplasms -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.